A comprehensive view of Rx-to-OTC Switch. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
MN HF4313: Coverage of over-the-counter contraceptive drugs, devices, and products by insurers and medical assistance required.
Published:
March 25, 2024
by Minnesota 93rd Legislature 2023-2024
|
Perrigo's Opill, the first daily birth control pill available without a prescription in the US, begins shipping to retailers nationwide and online pre-orders open; manufacturer's suggested retail price at set at US$19.99 to US$49.99
Published:
March 04, 2024
by PR Newswire
|
MN HF3976: Health plans required to cover over-the-counter contraceptives approved by United States Food and Drug Administration.
Published:
February 26, 2024
by Minnesota 93rd Legislature 2023-2024
|
MN SF3794: Over-the-counter contraceptives approved by the United States Food and Drug Administration health plans coverage requirement
Published:
February 15, 2024
by Minnesota 93rd Legislature 2023-2024
|
Opill, the first OTC birth control pill approved in the US, is set to be launched by Perrigo in Q1 2024; many states are enacting laws that enable pharmacists to prescribe birth control without a doctor's prescription, with 29 states already allowing this
Published:
January 15, 2024
by Philadelphia Tribune
|
Ask us about our Government & Public Policy market view